These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3159710)

  • 1. Comparative in-vitro activity of ciprofloxacin against non-fermenters.
    Husson MO; Izard D; Bouillet L; Leclerc H
    J Antimicrob Chemother; 1985 Apr; 15(4):457-62. PubMed ID: 3159710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of ciprofloxacin compared with other agents against recent hospital isolates.
    Rubinstein E; Mark Z; Samra Y; Alkan M; Berger S
    Chemioterapia; 1986 Apr; 5(2):75-82. PubMed ID: 2939966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative "in vitro" activity of ciprofloxacin (Bay o9867) and other antimicrobial agents against urinary bacterial isolates.
    Piccolomini R; Ravagnan G
    Chemioterapia; 1986 Aug; 5(4):249-56. PubMed ID: 3769047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
    Petit JC; Richard G; Burghoffer B; Daguet GL
    Pathol Biol (Paris); 1982 Jun; 30(6):426-31. PubMed ID: 6810286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of ciprofloxacin against resistant clinical isolates.
    Kelley SG; Bertram MA; Young LS
    J Antimicrob Chemother; 1986 Mar; 17(3):281-6. PubMed ID: 2939048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development and current status of Pseudomonas aeruginosa sensitivity to antibiotics].
    Duval J; Soussy CJ
    Presse Med; 1984 Mar; 13(13):763-7. PubMed ID: 6231591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro antibacterial activity of ciprofloxacin against uropathogenic organisms].
    Allocati N; Catamo G; Cellini L
    Boll Soc Ital Biol Sper; 1984 Oct; 60(10):1927-33. PubMed ID: 6440583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
    Bassey CM; Baltch AL; Smith RP
    J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of bactericidal curves in the optimal selection of a beta-lactam-aminoglycoside combination on Pseudomonas aeruginosa. In vitro study of 40 strains of Pseudomonas aeruginosa isolated in pediatric intensive care units].
    Lambert-Zechovsky N; Bingen E; Guihaire E; Nancy C; Mercier JC; Beaufils F
    Presse Med; 1986 Dec; 15(46):2309-12. PubMed ID: 2949273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory and bactericidal activities of amifloxacin, a new quinolone carboxylic acid, compared with those of seven other antimicrobial agents.
    Baltch AL; Sutphen NT; Smith RP; Conley PE
    Clin Ther; 1984; 7(1):73-80. PubMed ID: 6440708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
    King A; Phillips I
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-pseudomonal activity of HR 810.
    Husson MO; Izard D; Bryskier A; Leclerc H
    Infection; 1985; 13(2):85-6. PubMed ID: 3922898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of ciprofloxacin against pediatric pathogens.
    Weber AH; Scribner RK; Marks MI
    Chemotherapy; 1985; 31(6):456-65. PubMed ID: 2934233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The comparative in-vitro activity of pefloxacin.
    King A; Phillips I
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():1-10. PubMed ID: 2940213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro study of the activity of ciprofloxacin alone and in combination against strains of Pseudomonas aeruginosa with multiple antibiotic resistance.
    Davies GS; Cohen J
    J Antimicrob Chemother; 1985 Dec; 16(6):713-7. PubMed ID: 2936706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods.
    Moody JA; Gerding DN; Peterson LR
    Am J Med; 1987 Apr; 82(4A):44-54. PubMed ID: 3107380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro activity of ciprofloxacin and other antibacterial agents against Pseudomonas aeruginosa and Pseudomonas cepacia from cystic fibrosis patients.
    Klinger JD; Aronoff SC
    J Antimicrob Chemother; 1985 Jun; 15(6):679-84. PubMed ID: 3161856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of ciprofloxacin combined with azlocillin.
    Moody JA; Peterson LR; Gerding DN
    Antimicrob Agents Chemother; 1985 Dec; 28(6):849-50. PubMed ID: 2935078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of ciprofloxacin against aminoglycoside-sensitive and -resistant gram-negative rods.
    Speciale A; Blandino G; Pellegrino MB; Borghi P; Caccamo F
    Chemioterapia; 1986 Jun; 5(3):196-9. PubMed ID: 2941174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro activity of ciprofloxacin and other antimicrobial agents against aminoglycoside-resistant gram-negative rods and microorganisms isolated from patients with bacteremia.
    Weinstein MP
    Chemotherapy; 1986; 32(5):446-52. PubMed ID: 3757586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.